Cart is empty New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals that 3 to 4-year-olds in rural areas are more likely to be living with overweight and abdominal obesity (excess fat around waist), and spend more time on screens than their urban counterparts.
Once-daily oral treatment for obesity that mimics metabolic effects of gastric bypass shows promise in study
A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive preliminary data for the safe and effective redirection of nutrient absorption into the lower intestine, the weight loss and metabolic management mechanism behind gastric bypass surgery.
How your genes interact with your environment changes your disease risk. New research counts the ways
Sitting in my doctor’s examination room, I was surprised when she told me, “Genetics don’t really matter for chronic disease.” Rather, she continued, “A person’s lifestyle, what they eat, and how much they exercise, determine whether they get heart disease.”
Vision loss and damage could be tied to elevated eye pressure
One of the world’s leading causes of irreversible vision loss could begin with elevated eye pressure, according to a recent study published in Ophthalmology Science.
Yellow fever vaccination: How strong immune responses are triggered
The yellow fever vaccination using the live-attenuated YF17D vaccine is one of the most effective immunizations available. A single dose provides long-lasting protection against the disease.
The Florida group chipping away at public benefits one state at a time
As an Arizona bill to block people from using government aid to buy soda headed to the governor’s desk in April, the nation’s top health official joined Arizona lawmakers in the state Capitol to celebrate its passage.
GSK buys liver disease drug for up to $2 bn
British pharmaceutical giant GlaxoSmithKline announced Wednesday the acquisition of a drug under development to treat a common form of liver disease, in a deal worth up to $2 billion.
Study reveals distinct mechanisms of action of tirzepatide and semaglutide
New animal research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals distinct metabolic adjustments to tirzepatide and semaglutide treatment, with tirzepatide temporarily increasing energy expenditure and semaglutide initially reducing energy expenditure. Importantly, the biggest metabolic changes happen directly after treatment and disappear quickly after treatment is stopped.
Speaking more than one language can add layers to stroke recovery
You might not put a lot of thought into what it takes to speak, but speaking keeps your brain busy. In every conversation, multiple regions activate to process sounds, give words meaning and control the muscles that move your mouth.
Health disparities in US territories: Puerto Rico reports highest rates of poor physical health compared to 50 states
A new study found that people living in Puerto Rico, Guam, and the U.S. Virgin Islands reported worse overall physical health than those living in the states.